OLISEC LTD
Company number 14225630 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
OLISEC LTD - Analysis Report
Company Number: 14225630
Analysis Date: 2025-07-20 15:49 UTC
Financial Health Assessment of OLISEC LTD
1. Financial Health Score: D
Explanation:
OLISEC LTD’s financial profile shows concerning signs of distress, primarily due to persistent negative working capital and a critically low net asset base (£135). While the company remains active and compliant with filing deadlines, its liquidity position is weak with current liabilities significantly exceeding current assets. This score reflects a fragile financial state that requires prompt remedial action to avoid further deterioration.
2. Key Vital Signs
| Metric | 2024 | Interpretation |
|---|---|---|
| Fixed Assets | £20,880 | Tangible and intangible assets are modest but stable, indicating some investment in long-term resources. |
| Cash at Bank | £5,026 | Small cash reserves, increased from prior year, indicating some improvement in liquidity. |
| Current Liabilities | £16,554 | High short-term obligations exceeding cash and current assets, indicating liquidity stress. |
| Net Current Assets (Working Capital) | -£11,528 | Persistent negative working capital suggests the company cannot cover short-term debts from current assets—a symptom of financial strain. |
| Net Assets (Equity) | £135 | Extremely low equity, indicating the company is nearly insolvent from a balance sheet perspective. |
| Total Liabilities (Short + Long Term) | £25,771 | Total liabilities significantly outweigh assets, highlighting financial vulnerability. |
3. Diagnosis
The financial "vital signs" paint a picture of a company struggling with liquidity and solvency challenges. The persistent negative working capital ("symptom of distress") means OLISEC LTD does not have enough short-term assets to meet its immediate liabilities, risking cash flow crises. This liquidity squeeze could impair day-to-day operations and supplier relationships.
The net asset value (equity) of only £135 is alarmingly low for a trading company, indicating that liabilities almost fully consume all assets. This thin equity buffer exposes the company to financial shocks and makes it difficult to attract external funding. The amortisation of goodwill and depreciation of tangible assets further reduce asset values over time.
Despite these red flags, the company has maintained compliance with statutory filings and is not in liquidation or administration, suggesting some operational continuity. The increase in cash from £2,205 to £5,026 hints at improved cash management or possibly new financing, but this alone is insufficient to offset overall financial weakness.
4. Recommendations
Immediate Actions:
- Improve Liquidity: Prioritize increasing cash flow by accelerating receivables collection, negotiating extended payment terms with suppliers, or considering short-term financing to cover current liabilities.
- Cost Control: Review operating expenses to identify and reduce non-essential costs, preserving cash reserves.
- Capital Injection: Consider equity financing or shareholder loans to strengthen the balance sheet and increase net assets, providing a cushion against insolvency risks.
Medium-Term Strategies:
- Working Capital Management: Implement tighter inventory and debtor controls to improve net current assets.
- Debt Restructuring: Engage creditors to restructure or refinance long-term debts, easing pressure on near-term cash outflows.
- Business Model Review: Assess profitability drivers and market positioning in security systems services to ensure sustainable revenue growth.
Monitoring:
- Regularly track liquidity ratios and net asset position.
- Maintain transparent communication with stakeholders about financial health and recovery plans.
Medical Analogy Summary
OLISEC LTD currently suffers from "financial dehydration"—a liquidity shortage that threatens its survival. The company's "balance sheet pulse" is weak, with minimal equity to buffer shocks. Without prompt "treatment" in the form of cash inflows, cost reduction, and capital support, the business risks entering a critical state akin to "financial failure."
Sign in to generate a free AI analysis of this company — no password needed, just an email link.